IL6 and neoplasm: Furthermore, silibinin inhibits signaling of nuclear factor kappa B (NF-κB), a key factor to mediate the expression of tumor-promoting cytokines, such as interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) (Gao et al., 2015).